Skip to main content

CORRECTION article

Front. Immunol.
Sec. Alloimmunity and Transplantation
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1565304

Corrigendum: Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Scores and Clinical Outcomes after Haploidentical Stem Cell Transplantation in Pediatric Patients with Relapsed Neuroblastoma

Provisionally accepted
Eunseop Seo Eunseop Seo *
  • Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea

This article is a correction to:

  1. Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Scores and Clinical Outcomes after Haploidentical Stem Cell Transplantation in Pediatric Patients with Relapsed Neuroblastoma

    1. Read original article

The final, formatted version of the article will be published soon.

    Incorrect Funding In the published article, there was an error in the Funding statement. The original funding statement is as follows: “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIT) (2017R1A2B4008178). Additionally, this research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HA15C0007).”The correct Funding statement appears below.FUNDINGThe author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Research Foundation of Korea (NRF) grant, funded by the Korean government (MSIT) (2017R1A2B4008178, 2022R1F1A1075238). Additionally, this research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HA15C0007).The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

    Keywords: Neuroblastoma, PIRCHE, Haploidentical hematopoietic stem cell transplantation, Relapse/refractory, HLA mismatch

    Received: 23 Jan 2025; Accepted: 24 Jan 2025.

    Copyright: © 2025 Seo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Eunseop Seo, Samsung Genome Institute, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.